These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 19417774)
1. Troglitazone inhibits cell proliferation by attenuation of epidermal growth factor receptor signaling independent of peroxisome proliferator-activated receptor gamma. Li X; Yang X; Xu Y; Jiang X; Li X; Nan F; Tang H Cell Res; 2009 Jun; 19(6):720-32. PubMed ID: 19417774 [TBL] [Abstract][Full Text] [Related]
2. Apoptosis induced by troglitazone is both peroxisome proliferator-activated receptor-gamma- and ERK-dependent in human non-small lung cancer cells. Li M; Lee TW; Yim AP; Mok TS; Chen GG J Cell Physiol; 2006 Nov; 209(2):428-38. PubMed ID: 16883598 [TBL] [Abstract][Full Text] [Related]
3. Troglitazone attenuates epidermal growth factor receptor signaling independently of peroxisome proliferator-activated receptor in PC-3 cells. Zhu H; Pan X; Qi H; Wang X; Hou S; Han B; Liu Z; Xu L Oncol Rep; 2011 Jan; 25(1):81-90. PubMed ID: 21109961 [TBL] [Abstract][Full Text] [Related]
4. Activation of peroxisome proliferator-activated receptor-gamma by troglitazone (TGZ) inhibits human lung cell growth. Li M; Lee TW; Mok TS; Warner TD; Yim AP; Chen GG J Cell Biochem; 2005 Nov; 96(4):760-74. PubMed ID: 16149072 [TBL] [Abstract][Full Text] [Related]
5. Cytoprotective effect of tauroursodeoxycholate on hepatocyte apoptosis induced by peroxisome proliferator-activated receptor gamma ligand. Nonaka M; Tazuma S; Hyogo H; Kanno K; Chayama K J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e198-206. PubMed ID: 17868335 [TBL] [Abstract][Full Text] [Related]
6. A PPARgamma agonist inhibits aldosterone-induced mesangial cell proliferation by blocking ROS-dependent EGFR intracellular signaling. Yuan Y; Zhang A; Huang S; Ding G; Chen R Am J Physiol Renal Physiol; 2011 Feb; 300(2):F393-402. PubMed ID: 21123490 [TBL] [Abstract][Full Text] [Related]
7. Troglitazone inhibits endothelial cell proliferation through suppression of casein kinase 2 activity. Lee KS; Park JH; Lee S; Lim HJ; Jang Y; Park HY Biochem Biophys Res Commun; 2006 Jul; 346(1):83-8. PubMed ID: 16759638 [TBL] [Abstract][Full Text] [Related]
8. Disruption of ERalpha signalling pathway by PPARgamma agonists: evidences of PPARgamma-independent events in two hormone-dependent breast cancer cell lines. Lecomte J; Flament S; Salamone S; Boisbrun M; Mazerbourg S; Chapleur Y; Grillier-Vuissoz I Breast Cancer Res Treat; 2008 Dec; 112(3):437-51. PubMed ID: 18204896 [TBL] [Abstract][Full Text] [Related]
9. Role of PPARgamma and EGFR signalling in the urothelial terminal differentiation programme. Varley CL; Stahlschmidt J; Lee WC; Holder J; Diggle C; Selby PJ; Trejdosiewicz LK; Southgate J J Cell Sci; 2004 Apr; 117(Pt 10):2029-36. PubMed ID: 15054105 [TBL] [Abstract][Full Text] [Related]
10. Activation of PPAR{gamma} by curcumin inhibits Moser cell growth and mediates suppression of gene expression of cyclin D1 and EGFR. Chen A; Xu J Am J Physiol Gastrointest Liver Physiol; 2005 Mar; 288(3):G447-56. PubMed ID: 15486348 [TBL] [Abstract][Full Text] [Related]
11. EGR1 expression: a calcium and ERK1/2 mediated PPARγ-independent event involved in the antiproliferative effect of 15-deoxy-Δ12,14-prostaglandin J2 and thiazolidinediones in breast cancer cells. Chbicheb S; Yao X; Rodeau JL; Salamone S; Boisbrun M; Thiel G; Spohn D; Grillier-Vuissoz I; Chapleur Y; Flament S; Mazerbourg S Biochem Pharmacol; 2011 May; 81(9):1087-97. PubMed ID: 21338579 [TBL] [Abstract][Full Text] [Related]
12. New troglitazone derivatives devoid of PPARγ agonist activity display an increased antiproliferative effect in both hormone-dependent and hormone-independent breast cancer cell lines. Colin C; Salamone S; Grillier-Vuissoz I; Boisbrun M; Kuntz S; Lecomte J; Chapleur Y; Flament S Breast Cancer Res Treat; 2010 Nov; 124(1):101-10. PubMed ID: 20054646 [TBL] [Abstract][Full Text] [Related]
13. Phorbol ester potentiates the growth inhibitory effects of troglitazone via up-regulation of PPARgamma in A549 cells. Kim HJ; Woo IS; Kang ES; Eun SY; Kim GH; Ham SA; Kim HJ; Lee JH; Chang KC; Kim JH; Lee HT; Seo HG Biochem Biophys Res Commun; 2006 Oct; 349(2):660-7. PubMed ID: 16945329 [TBL] [Abstract][Full Text] [Related]
14. Induction of G1 phase arrest and apoptosis in MDA-MB-231 breast cancer cells by troglitazone, a synthetic peroxisome proliferator-activated receptor gamma (PPARgamma) ligand. Yu HN; Lee YR; Noh EM; Lee KS; Kim JS; Song EK; Han MK; Lee YC; Kwon KB; Lee SJ; Youn HJ; Jung SH Cell Biol Int; 2008 Aug; 32(8):906-12. PubMed ID: 18474441 [TBL] [Abstract][Full Text] [Related]
15. Urine acidification has no effect on peroxisome proliferator-activated receptor (PPAR) signaling or epidermal growth factor (EGF) expression in rat urinary bladder urothelium. Achanzar WE; Moyer CF; Marthaler LT; Gullo R; Chen SJ; French MH; Watson LM; Rhodes JW; Kozlosky JC; White MR; Foster WR; Burgun JJ; Car BD; Cosma GN; Dominick MA Toxicol Appl Pharmacol; 2007 Sep; 223(3):246-56. PubMed ID: 17663016 [TBL] [Abstract][Full Text] [Related]
16. Peroxisome proliferator-activated receptor gamma regulates expression of signal transducer and activator of transcription 5A. Olsen H; Haldosén LA Exp Cell Res; 2006 May; 312(8):1371-80. PubMed ID: 16457814 [TBL] [Abstract][Full Text] [Related]
17. Troglitazone inhibits cell growth and induces apoptosis of B-cell acute lymphoblastic leukemia cells with t(14;18). Takenokuchi M; Saigo K; Nakamachi Y; Kawano S; Hashimoto M; Fujioka T; Koizumi T; Tatsumi E; Kumagai S Acta Haematol; 2006; 116(1):30-40. PubMed ID: 16809887 [TBL] [Abstract][Full Text] [Related]
18. Troglitazone, a peroxisome proliferator-activated receptor-gamma agonist, decreases tau phosphorylation in CHOtau4R cells. d'Abramo C; Ricciarelli R; Pronzato MA; Davies P J Neurochem; 2006 Aug; 98(4):1068-77. PubMed ID: 16787414 [TBL] [Abstract][Full Text] [Related]
19. Rosiglitazone induces caveolin-1 by PPARgamma-dependent and PPRE-independent mechanisms: the role of EGF receptor signaling and its effect on cancer cell drug resistance. Tencer L; Burgermeister E; Ebert MP; Liscovitch M Anticancer Res; 2008; 28(2A):895-906. PubMed ID: 18507034 [TBL] [Abstract][Full Text] [Related]
20. The synergistic anticancer effect of troglitazone combined with aspirin causes cell cycle arrest and apoptosis in human lung cancer cells. Yan KH; Yao CJ; Chang HY; Lai GM; Cheng AL; Chuang SE Mol Carcinog; 2010 Mar; 49(3):235-46. PubMed ID: 19908241 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]